US Patent Issued to SCYNEXIS on April 7 for "Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia" (New Jersey, Florida Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,266, issued on April 7, was assigned to SCYNEXIS INC. (Jersey City, N.J.).

"Triterpenoid antifungals for the treatment or prevention of Pneumocystis spp. pneumonia" was invented by David A. Angulo Gonzalez (Palmetto Bay, Fla.) and Stephen Andrew Barat (Mendham, N.J.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Eufumafungin derivative triterpenoid antifungal compounds are used to treat and/or prevent Pneumocystis pneumonia (PCP) due to their unexpected efficacy against Pneumocystis spp. including their ability to reduce the lung burden of cyst and trophic forms of this fungi. The enfumafungin derivative triterpenoids (or pharmaceutically acceptable...